4.7 Review

M2 macrophages in kidney disease: biology, therapies, and perspectives

Journal

KIDNEY INTERNATIONAL
Volume 95, Issue 4, Pages 760-773

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2018.10.041

Keywords

anti-inflammatory; kidney disease; macrophage; M2; polarization; therapy

Funding

  1. National Health and Medical Research Council of Australia [1141330, 1146156]
  2. National Health and Medical Research Council of Australia [1146156, 1141330] Funding Source: NHMRC

Ask authors/readers for more resources

Tissue macrophages are crucial players in homeostasis, inflammation, and immunity. They are characterized by heterogeneity and plasticity, due to which they display a continuum of phenotypes with M1/M2 presenting 2 extremes of this continuum. M2 macrophages are usually termed in the literature as anti-inflammatory and wound healing. Substantial progress has been made in elucidating the biology of M2 macrophages and their potential for clinical translation. In this review we discuss the current state of knowledge in M2 macrophage research with an emphasis on kidney disease. We explore their therapeutic potential and the challenges in using them as cellular therapies. Some new regulators that shape macrophage polarization and potential areas for future research are also examined.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available